Q32 Bio Inc.QTTBNASDAQ
Loading
Operating Expenses Over TimeContracting
Percentile Rank22
3Y CAGR-7.4%
5Y CAGR-21.7%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
-7.4%/yr
vs -8.0%/yr prior
5Y CAGR
-21.7%/yr
Recent acceleration
Acceleration
+0.6pp
Accelerating
Percentile
P22
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $36.44M | -44.5% |
| 2024 | $65.61M | +57.7% |
| 2023 | $41.60M | -9.3% |
| 2022 | $45.88M | -61.9% |
| 2021 | $120.38M | -3.0% |
| 2020 | $124.06M | +17.8% |
| 2019 | $105.29M | +64.6% |
| 2018 | $63.96M | +120.8% |
| 2017 | $28.97M | +196.9% |
| 2016 | $9.76M | - |